National Center in HIV Epidemiology and Clinical Research Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2004
NCT00400738
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

lopinavir (Kaletra) (1 trial)

ritonavir (Norvir) (1 trial)

saquinavir (invirase) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 2)

Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 3